Parasites as potential targets for cancer immunotherapy

J Cancer Res Clin Oncol. 2023 Aug;149(10):8027-8038. doi: 10.1007/s00432-023-04694-2. Epub 2023 Mar 22.

Abstract

Parasites and cancers have some common antigens. Much scientific evidence in the human population, animal models, and in vitro experiments exhibit that parasites have significant anti-cancer effects. The larval stage of the tapeworm Echinococcus granulosus, Toxoplasma gondii, Trypanosoma cruzy, Plasmodium's, and Trichinella spiralis are among the parasites that have been subjects of anti-cancer research in the last decades. Anti-tumor effects of parasites may be due to the direct impact of the parasites per se or indirectly due to the immune response raised against common antigens between malignant cells and parasites. This manuscript reviews the anti-cancer effects of parasites and possible mechanisms of these effects. Options for using parasites or their antigens for cancer treatment in the future have been discussed.

Keywords: Cancer; Cancer immunotherapy; Parasites.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Immunotherapy
  • Neoplasms* / therapy
  • Parasites*
  • Toxoplasma*